Bolt Biotherapeutics, Inc. (BOLT)
6.30
-0.13
(-2.02%)
USD |
NASDAQ |
Nov 10, 16:00
6.28
-0.02
(-0.32%)
After-Hours: 20:00
Bolt Biotherapeutics Cash from Operations (Annual) : -39.85M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -39.85M |
| December 31, 2024 | -61.29M |
| December 31, 2023 | -69.52M |
| December 31, 2022 | -76.50M |
| Date | Value |
|---|---|
| December 31, 2021 | -57.07M |
| December 31, 2020 | -47.31M |
| December 31, 2019 | -26.34M |
| December 31, 2018 | -9.872M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Caribou Biosciences, Inc. | -110.99M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |
| Sangamo Therapeutics, Inc. | -97.21M |
| Sarepta Therapeutics, Inc. | -222.54M |